Global Fecal Transplant Treatment Market Research Report 2023

November 2023 | 92 pages | ID: GFE69EF2330DEN
QYResearch

Abstracts

This report aims to provide a comprehensive presentation of the global market for Fecal Transplant Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fecal Transplant Treatment.

The Fecal Transplant Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Fecal Transplant Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Fecal Transplant Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

• Enterome Bioscience
• Rebiotix
• Ritter Pharmaceuticals
• Finch Therapeutics
• Crestovo
• MaaT Pharma
• Seres Therapeutics
• Second Genome
• OpenBiome
• MicroBiome Therapeutics

Segment by Type

• Fecal Transfusion
• Fecal Bacteria Therapy
• Fecal Enema
• Fecal Transplant
• Others

Segment by Application

• Parkinson's Diseaseo
• Obesity
• Autism
• Clostridium Difficile Infection
• Diabetes Mellitus
• Others

By Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Fecal Transplant Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Fecal Transplant Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Fecal Transfusion
  1.2.3 Fecal Bacteria Therapy
  1.2.4 Fecal Enema
  1.2.5 Fecal Transplant
  1.2.6 Others
1.3 Market by Application
  1.3.1 Global Fecal Transplant Treatment Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Parkinson's Diseaseo
  1.3.3 Obesity
  1.3.4 Autism
  1.3.5 Clostridium Difficile Infection
  1.3.6 Diabetes Mellitus
  1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Fecal Transplant Treatment Market Perspective (2018-2029)
2.2 Fecal Transplant Treatment Growth Trends by Region
  2.2.1 Global Fecal Transplant Treatment Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Fecal Transplant Treatment Historic Market Size by Region (2018-2023)
  2.2.3 Fecal Transplant Treatment Forecasted Market Size by Region (2024-2029)
2.3 Fecal Transplant Treatment Market Dynamics
  2.3.1 Fecal Transplant Treatment Industry Trends
  2.3.2 Fecal Transplant Treatment Market Drivers
  2.3.3 Fecal Transplant Treatment Market Challenges
  2.3.4 Fecal Transplant Treatment Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Fecal Transplant Treatment Players by Revenue
  3.1.1 Global Top Fecal Transplant Treatment Players by Revenue (2018-2023)
  3.1.2 Global Fecal Transplant Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Fecal Transplant Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fecal Transplant Treatment Revenue
3.4 Global Fecal Transplant Treatment Market Concentration Ratio
  3.4.1 Global Fecal Transplant Treatment Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Fecal Transplant Treatment Revenue in 2022
3.5 Fecal Transplant Treatment Key Players Head office and Area Served
3.6 Key Players Fecal Transplant Treatment Product Solution and Service
3.7 Date of Enter into Fecal Transplant Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 FECAL TRANSPLANT TREATMENT BREAKDOWN DATA BY TYPE

4.1 Global Fecal Transplant Treatment Historic Market Size by Type (2018-2023)
4.2 Global Fecal Transplant Treatment Forecasted Market Size by Type (2024-2029)

5 FECAL TRANSPLANT TREATMENT BREAKDOWN DATA BY APPLICATION

5.1 Global Fecal Transplant Treatment Historic Market Size by Application (2018-2023)
5.2 Global Fecal Transplant Treatment Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Fecal Transplant Treatment Market Size (2018-2029)
6.2 North America Fecal Transplant Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Fecal Transplant Treatment Market Size by Country (2018-2023)
6.4 North America Fecal Transplant Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Fecal Transplant Treatment Market Size (2018-2029)
7.2 Europe Fecal Transplant Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Fecal Transplant Treatment Market Size by Country (2018-2023)
7.4 Europe Fecal Transplant Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Fecal Transplant Treatment Market Size (2018-2029)
8.2 Asia-Pacific Fecal Transplant Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Fecal Transplant Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Fecal Transplant Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Fecal Transplant Treatment Market Size (2018-2029)
9.2 Latin America Fecal Transplant Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Fecal Transplant Treatment Market Size by Country (2018-2023)
9.4 Latin America Fecal Transplant Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Fecal Transplant Treatment Market Size (2018-2029)
10.2 Middle East & Africa Fecal Transplant Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Fecal Transplant Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Fecal Transplant Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Enterome Bioscience
  11.1.1 Enterome Bioscience Company Detail
  11.1.2 Enterome Bioscience Business Overview
  11.1.3 Enterome Bioscience Fecal Transplant Treatment Introduction
  11.1.4 Enterome Bioscience Revenue in Fecal Transplant Treatment Business (2018-2023)
  11.1.5 Enterome Bioscience Recent Development
11.2 Rebiotix
  11.2.1 Rebiotix Company Detail
  11.2.2 Rebiotix Business Overview
  11.2.3 Rebiotix Fecal Transplant Treatment Introduction
  11.2.4 Rebiotix Revenue in Fecal Transplant Treatment Business (2018-2023)
  11.2.5 Rebiotix Recent Development
11.3 Ritter Pharmaceuticals
  11.3.1 Ritter Pharmaceuticals Company Detail
  11.3.2 Ritter Pharmaceuticals Business Overview
  11.3.3 Ritter Pharmaceuticals Fecal Transplant Treatment Introduction
  11.3.4 Ritter Pharmaceuticals Revenue in Fecal Transplant Treatment Business (2018-2023)
  11.3.5 Ritter Pharmaceuticals Recent Development
11.4 Finch Therapeutics
  11.4.1 Finch Therapeutics Company Detail
  11.4.2 Finch Therapeutics Business Overview
  11.4.3 Finch Therapeutics Fecal Transplant Treatment Introduction
  11.4.4 Finch Therapeutics Revenue in Fecal Transplant Treatment Business (2018-2023)
  11.4.5 Finch Therapeutics Recent Development
11.5 Crestovo
  11.5.1 Crestovo Company Detail
  11.5.2 Crestovo Business Overview
  11.5.3 Crestovo Fecal Transplant Treatment Introduction
  11.5.4 Crestovo Revenue in Fecal Transplant Treatment Business (2018-2023)
  11.5.5 Crestovo Recent Development
11.6 MaaT Pharma
  11.6.1 MaaT Pharma Company Detail
  11.6.2 MaaT Pharma Business Overview
  11.6.3 MaaT Pharma Fecal Transplant Treatment Introduction
  11.6.4 MaaT Pharma Revenue in Fecal Transplant Treatment Business (2018-2023)
  11.6.5 MaaT Pharma Recent Development
11.7 Seres Therapeutics
  11.7.1 Seres Therapeutics Company Detail
  11.7.2 Seres Therapeutics Business Overview
  11.7.3 Seres Therapeutics Fecal Transplant Treatment Introduction
  11.7.4 Seres Therapeutics Revenue in Fecal Transplant Treatment Business (2018-2023)
  11.7.5 Seres Therapeutics Recent Development
11.8 Second Genome
  11.8.1 Second Genome Company Detail
  11.8.2 Second Genome Business Overview
  11.8.3 Second Genome Fecal Transplant Treatment Introduction
  11.8.4 Second Genome Revenue in Fecal Transplant Treatment Business (2018-2023)
  11.8.5 Second Genome Recent Development
11.9 OpenBiome
  11.9.1 OpenBiome Company Detail
  11.9.2 OpenBiome Business Overview
  11.9.3 OpenBiome Fecal Transplant Treatment Introduction
  11.9.4 OpenBiome Revenue in Fecal Transplant Treatment Business (2018-2023)
  11.9.5 OpenBiome Recent Development
11.10 MicroBiome Therapeutics
  11.10.1 MicroBiome Therapeutics Company Detail
  11.10.2 MicroBiome Therapeutics Business Overview
  11.10.3 MicroBiome Therapeutics Fecal Transplant Treatment Introduction
  11.10.4 MicroBiome Therapeutics Revenue in Fecal Transplant Treatment Business (2018-2023)
  11.10.5 MicroBiome Therapeutics Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Fecal Transplant Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Fecal Transfusion
Table 3. Key Players of Fecal Bacteria Therapy
Table 4. Key Players of Fecal Enema
Table 5. Key Players of Fecal Transplant
Table 6. Key Players of Others
Table 7. Global Fecal Transplant Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Fecal Transplant Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Fecal Transplant Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Fecal Transplant Treatment Market Share by Region (2018-2023)
Table 11. Global Fecal Transplant Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Fecal Transplant Treatment Market Share by Region (2024-2029)
Table 13. Fecal Transplant Treatment Market Trends
Table 14. Fecal Transplant Treatment Market Drivers
Table 15. Fecal Transplant Treatment Market Challenges
Table 16. Fecal Transplant Treatment Market Restraints
Table 17. Global Fecal Transplant Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Fecal Transplant Treatment Market Share by Players (2018-2023)
Table 19. Global Top Fecal Transplant Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fecal Transplant Treatment as of 2022)
Table 20. Ranking of Global Top Fecal Transplant Treatment Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Fecal Transplant Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Fecal Transplant Treatment Product Solution and Service
Table 24. Date of Enter into Fecal Transplant Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Fecal Transplant Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Fecal Transplant Treatment Revenue Market Share by Type (2018-2023)
Table 28. Global Fecal Transplant Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Fecal Transplant Treatment Revenue Market Share by Type (2024-2029)
Table 30. Global Fecal Transplant Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Fecal Transplant Treatment Revenue Market Share by Application (2018-2023)
Table 32. Global Fecal Transplant Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Fecal Transplant Treatment Revenue Market Share by Application (2024-2029)
Table 34. North America Fecal Transplant Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Fecal Transplant Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Fecal Transplant Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Fecal Transplant Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Fecal Transplant Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Fecal Transplant Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Fecal Transplant Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Fecal Transplant Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Fecal Transplant Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Fecal Transplant Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Fecal Transplant Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Fecal Transplant Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Fecal Transplant Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Fecal Transplant Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Fecal Transplant Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 49. Enterome Bioscience Company Detail
Table 50. Enterome Bioscience Business Overview
Table 51. Enterome Bioscience Fecal Transplant Treatment Product
Table 52. Enterome Bioscience Revenue in Fecal Transplant Treatment Business (2018-2023) & (US$ Million)
Table 53. Enterome Bioscience Recent Development
Table 54. Rebiotix Company Detail
Table 55. Rebiotix Business Overview
Table 56. Rebiotix Fecal Transplant Treatment Product
Table 57. Rebiotix Revenue in Fecal Transplant Treatment Business (2018-2023) & (US$ Million)
Table 58. Rebiotix Recent Development
Table 59. Ritter Pharmaceuticals Company Detail
Table 60. Ritter Pharmaceuticals Business Overview
Table 61. Ritter Pharmaceuticals Fecal Transplant Treatment Product
Table 62. Ritter Pharmaceuticals Revenue in Fecal Transplant Treatment Business (2018-2023) & (US$ Million)
Table 63. Ritter Pharmaceuticals Recent Development
Table 64. Finch Therapeutics Company Detail
Table 65. Finch Therapeutics Business Overview
Table 66. Finch Therapeutics Fecal Transplant Treatment Product
Table 67. Finch Therapeutics Revenue in Fecal Transplant Treatment Business (2018-2023) & (US$ Million)
Table 68. Finch Therapeutics Recent Development
Table 69. Crestovo Company Detail
Table 70. Crestovo Business Overview
Table 71. Crestovo Fecal Transplant Treatment Product
Table 72. Crestovo Revenue in Fecal Transplant Treatment Business (2018-2023) & (US$ Million)
Table 73. Crestovo Recent Development
Table 74. MaaT Pharma Company Detail
Table 75. MaaT Pharma Business Overview
Table 76. MaaT Pharma Fecal Transplant Treatment Product
Table 77. MaaT Pharma Revenue in Fecal Transplant Treatment Business (2018-2023) & (US$ Million)
Table 78. MaaT Pharma Recent Development
Table 79. Seres Therapeutics Company Detail
Table 80. Seres Therapeutics Business Overview
Table 81. Seres Therapeutics Fecal Transplant Treatment Product
Table 82. Seres Therapeutics Revenue in Fecal Transplant Treatment Business (2018-2023) & (US$ Million)
Table 83. Seres Therapeutics Recent Development
Table 84. Second Genome Company Detail
Table 85. Second Genome Business Overview
Table 86. Second Genome Fecal Transplant Treatment Product
Table 87. Second Genome Revenue in Fecal Transplant Treatment Business (2018-2023) & (US$ Million)
Table 88. Second Genome Recent Development
Table 89. OpenBiome Company Detail
Table 90. OpenBiome Business Overview
Table 91. OpenBiome Fecal Transplant Treatment Product
Table 92. OpenBiome Revenue in Fecal Transplant Treatment Business (2018-2023) & (US$ Million)
Table 93. OpenBiome Recent Development
Table 94. MicroBiome Therapeutics Company Detail
Table 95. MicroBiome Therapeutics Business Overview
Table 96. MicroBiome Therapeutics Fecal Transplant Treatment Product
Table 97. MicroBiome Therapeutics Revenue in Fecal Transplant Treatment Business (2018-2023) & (US$ Million)
Table 98. MicroBiome Therapeutics Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Fecal Transplant Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Fecal Transplant Treatment Market Share by Type: 2022 VS 2029
Figure 3. Fecal Transfusion Features
Figure 4. Fecal Bacteria Therapy Features
Figure 5. Fecal Enema Features
Figure 6. Fecal Transplant Features
Figure 7. Others Features
Figure 8. Global Fecal Transplant Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Fecal Transplant Treatment Market Share by Application: 2022 VS 2029
Figure 10. Parkinson's Diseaseo Case Studies
Figure 11. Obesity Case Studies
Figure 12. Autism Case Studies
Figure 13. Clostridium Difficile Infection Case Studies
Figure 14. Diabetes Mellitus Case Studies
Figure 15. Others Case Studies
Figure 16. Fecal Transplant Treatment Report Years Considered
Figure 17. Global Fecal Transplant Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Fecal Transplant Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Fecal Transplant Treatment Market Share by Region: 2022 VS 2029
Figure 20. Global Fecal Transplant Treatment Market Share by Players in 2022
Figure 21. Global Top Fecal Transplant Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fecal Transplant Treatment as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Fecal Transplant Treatment Revenue in 2022
Figure 23. North America Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Fecal Transplant Treatment Market Share by Country (2018-2029)
Figure 25. United States Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Fecal Transplant Treatment Market Share by Country (2018-2029)
Figure 29. Germany Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Fecal Transplant Treatment Market Share by Region (2018-2029)
Figure 37. China Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Fecal Transplant Treatment Market Share by Country (2018-2029)
Figure 45. Mexico Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Fecal Transplant Treatment Market Share by Country (2018-2029)
Figure 49. Turkey Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Fecal Transplant Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Enterome Bioscience Revenue Growth Rate in Fecal Transplant Treatment Business (2018-2023)
Figure 52. Rebiotix Revenue Growth Rate in Fecal Transplant Treatment Business (2018-2023)
Figure 53. Ritter Pharmaceuticals Revenue Growth Rate in Fecal Transplant Treatment Business (2018-2023)
Figure 54. Finch Therapeutics Revenue Growth Rate in Fecal Transplant Treatment Business (2018-2023)
Figure 55. Crestovo Revenue Growth Rate in Fecal Transplant Treatment Business (2018-2023)
Figure 56. MaaT Pharma Revenue Growth Rate in Fecal Transplant Treatment Business (2018-2023)
Figure 57. Seres Therapeutics Revenue Growth Rate in Fecal Transplant Treatment Business (2018-2023)
Figure 58. Second Genome Revenue Growth Rate in Fecal Transplant Treatment Business (2018-2023)
Figure 59. OpenBiome Revenue Growth Rate in Fecal Transplant Treatment Business (2018-2023)
Figure 60. MicroBiome Therapeutics Revenue Growth Rate in Fecal Transplant Treatment Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed